Epidemiological and Clinical Characteristics of COVID-19 in Children: A Systematic Review and Meta-Analysis

Zhu, 2020, A novel coronavirus from patients with pneumonia in China, N Engl J Med., 382, 727, 10.1056/NEJMoa2001017

Coronavirus Disease 2019 (COVID-19) Situation Report-137

Wu, 2020, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention, JAMA., 323, 1239, 10.1001/jama.2020.2648

CDC, 2020, Coronavirus disease 2019 in children—United States, February 12-April 2, 2020, MMWR Morb Mortal Wkly Rep, 69, 422, 10.15585/mmwr.mm6914e4

Ma, 2020, The clinical characteristics of pediatric inpatients with SARS-CoV-2 infection: a meta-analysis and systematic review, J Med Virol., 10.1002/jmv.26208

Ding, 2020, Clinical characteristics of children with COVID-19: a meta-analysis, Front Pediatr., 8, 431, 10.3389/fped.2020.00431

Wang, 2020, Clinical characteristics of children with COVID-19: a rapid review and meta-analysis, Ann Transl Med., 8, 620, 10.21037/atm-20-3302

Gandhi, 2020, Asymptomatic transmission, the Achilles' heel of current strategies to control Covid-19, N Engl J Med., 382, 2158, 10.1056/NEJMe2009758

Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS Med., 6, e1000097, 10.1371/journal.pmed.1000097

Downes, 2016, Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS), BMJ Open., 6, e011458, 10.1136/bmjopen-2016-011458

2014, Quality Appraisal of Case Series Studies Checklist

Wan, 2014, Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range, BMC Med Res Methodol., 14, 135, 10.1186/1471-2288-14-135

L'Huillier, 2020, Culture-competent SARS-CoV-2 in nasopharynx of symptomatic neonates, children and adolescents, Emerg Infect Dis., 26, 2494, 10.3201/eid2610.202403

Heald-Sargent, 2020, Age-related differences in nasopharyngeal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) levels in patients with mild to moderate coronavirus disease 2019 (COVID-19), JAMA Pediatr., 174, 902, 10.1001/jamapediatrics.2020.3651

Colson, 2020, Children account for a small proportion of diagnoses of SARS-CoV-2 infection and do not exhibit greater viral loads than adults, Eur J Clin Microbiol Infect Dis., 39, 1983, 10.1007/s10096-020-03900-0

Dong, 2020, Epidemiology of COVID-19 among children in China, Pediatrics., 145, e20200702, 10.1542/peds.2020-0702

Xiao, 2020, Infectious SARS-CoV-2 in feces of patient with severe COVID-19, Emerg Infect Dis., 26, 1920, 10.3201/eid2608.200681

Mi Seon, 2020, Viral RNA load in mildly symptomatic and asymptomatic children with COVID-19, seoul, Emerg Infect Dis., 26, 2497, 10.3201/eid2610.202449

Xu, 2020, A follow-up study of children infected with SARS-CoV-2 from Western China, Ann Transl Med., 8, 623, 10.21037/atm-20-3192

Guo, 2020, Epidemiological and clinical features of pediatric COVID-19, BMC Med., 18, 250, 10.1186/s12916-020-01719-2

Guan, 2020, Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med., 382, 1708, 10.1056/NEJMoa2002032

Tang, 2020, Clinical characteristics of 20,662 patients with COVID-19 in mainland China: a systemic review and meta-analysis, medRxiv., 10.1101/2020.04.18.20070565

Wang, 2020, Survival analysis of hospital length of stay of novel coronavirus (COVID-19) pneumonia patients in Sichuan, China, medRxiv [Preprint], 10.1101/2020.04.07.20057299

Zhu, 2020, COVID-19 epidemic: clinical characteristics of patients in pediatric isolation ward, Clin Pediatr., 59, 1069, 10.1177/0009922820941228

Bwire, 2020, Coronavirus: why men are more vulnerable to covid-19 than women?, SN Compr Clin Med., 4, 1, 10.1007/s42399-020-00341-w

Sahu, 2020, C-reactive protein: a promising biomarker for poor prognosis in COVID-19 infection, Clin Chim Acta., 509, 91, 10.1016/j.cca.2020.06.013

Yu, 2020, Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China, Microbes Infect., 22, 74, 10.1016/j.micinf.2020.01.003

Kim, 2020, Rates of co-infection between SARS-CoV-2 and other respiratory pathogens, JAMA., 323, 2085, 10.1001/jama.2020.6266

Huang, 2020, Concomitant infection with COVID-19 and mycoplasma pneumoniae, Biomed J., 10.1016/j.bj.2020.07.002

Gayam, 2020, Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID-19 and mycoplasma pneumoniae in the USA, JAMA., 323, 2052, 10.1002/jmv.26026

Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet., 395, 1054, 10.1016/S0140-6736(20)30566-3

Omrani, 2014, Ribavirin and interferon alfa-2a for severe middle east respiratory syndrome coronavirus infection: a retrospective cohort study, Lancet Infect Dis., 14, 1090, 10.1016/S1473-3099(14)70920-X

Hao, 2020, Interferon-α2b spray inhalation did not shorten virus shedding time of SARS-CoV-2 in hospitalized patients: a preliminary matched case-control study, J Zhejiang Univ Sci B., 21, 628, 10.1631/jzus.B2000211

Udwadia, 2020, Hydroxychloroquine for COVID-19: what is our current state of knowledge?, J Assoc Physicians India., 68, 48

Cura, 2020, Characteristics and management of children with COVID-19 in Turkey, Balkan Med J., 10.4274/balkanmedj.galenos.2020.2020.7.52

Shekerdemian, 2020, Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units, JAMA Pediatr., 174, 1, 10.1001/jamapediatrics.2020.1948

Cavalcanti, 2020, Hydroxychloroquine with or without azithromycin in mild-to-moderate Covid-19, N Engl J Med., 10.1056/NEJMoa2019014

Wang, 2020, Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial, Lancet., 395, 1569, 10.1016/S0140-6736(20)31022-9

Solinas, 2020, A critical evaluation of glucocorticoids in the management of severe COVID-19, Cytokine Growth Factor Rev., 54, 8, 10.1016/j.cytogfr.2020.06.012

Quartuccio, 2020, Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: results from a single Italian centre study on tocilizumab versus standard of care, J Clin Virol., 129, 104444, 10.1016/j.jcv.2020.104444

Devasenapathy, 2020, Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis, CMAJ., 192, E745, 10.1503/cmaj.200642

Horby, 2020, Dexamethasone in hospitalized patients with Covid-19-preliminary report, N Engl J Med, 10.1101/2020.06.22.20137273

Fang, 2020, Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19, J Infect., 81, 147, 10.1016/j.jinf.2020.03.039

Bunyavanich, 2020, Nasal gene expression of angiotensin-converting enzyme 2 in children and adults, JAMA., 323, 2427, 10.1001/jama.2020.8707

Jiang, 2011, CD8 T cell responses to influenza virus infection in aged mice, Ageing Res Rev., 10, 422, 10.1016/j.arr.2011.02.001

Henry, 2020, COVID-19, ECMO, and lymphopenia: a word of caution, Lancet Respir Med., 8, e24, 10.1016/S2213-2600(20)30119-3

Bandi, 2020, African American children are at higher risk of COVID-19 infection, Pediatr Allergy Immunol., 29, 10, 10.1111/pai.13298

Dufort, 2020, Multisystem inflammatory syndrome in children in New York state, N Engl J Med., 383, 347, 10.1056/NEJMoa2021756

Verdoni, 2020, An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study, Lancet., 395, 1771, 10.1016/S0140-6736(20)31103-X

Whittaker, 2020, Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2, JAMA., 324, 259, 10.1001/jama.2020.10369